2
项与 Umbilical cord derived mesenchymal stem cell therapy (RESTEM) 相关的临床试验Phase 1 Study of Mesenchymal Stromal Cells, Umbilical Cord Lining Stem Cells (ULSC), in Patients With Polymyositis (PM) and Dermatomyositis (DM)
This study will investigate Umbilical Cord Lining Stem Cells (ULSC) as an investigational medicinal product and its use in patients with polymyositis (PM) or dermatomyositis (DM) to see if a single intravenous (IV) infusion of allogeneic umbilical cord lining stem cells (ULSC) safe, tolerable, and feasible to administer.
Phase 1/2a Study of Umbilical Cord Lining Stem Cells (ULSC) in Patients With ARDS Due to COVID-19
ULSC-CV-01 is a clinical trial that comprises both Phase 1 and Phase 2a, which will be conducted sequentially. This trial will evaluate the safety and potential efficacy of allogeneic Umbilical Cord Lining Stem Cells (ULSC), which are a type of umbilical cord tissue derived mesenchymal stem cells (MSC), with intravenous (IV) administration in hospitalized patients with acute respiratory distress syndrome (ARDS) due to COVID-19.
100 项与 Umbilical cord derived mesenchymal stem cell therapy (RESTEM) 相关的临床结果
100 项与 Umbilical cord derived mesenchymal stem cell therapy (RESTEM) 相关的转化医学
100 项与 Umbilical cord derived mesenchymal stem cell therapy (RESTEM) 相关的专利(医药)
100 项与 Umbilical cord derived mesenchymal stem cell therapy (RESTEM) 相关的药物交易